Jocelyn Anne Silvester, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Celiac Disease | 51 | 2024 | 821 | 11.900 |
Why?
|
Diet, Gluten-Free | 33 | 2024 | 283 | 6.970 |
Why?
|
Glutens | 23 | 2024 | 240 | 5.150 |
Why?
|
Patient Compliance | 9 | 2024 | 2690 | 1.310 |
Why?
|
Transglutaminases | 9 | 2021 | 197 | 1.250 |
Why?
|
Intestinal Mucosa | 11 | 2024 | 3032 | 0.950 |
Why?
|
Duodenum | 5 | 2024 | 490 | 0.880 |
Why?
|
Continuity of Patient Care | 3 | 2018 | 1069 | 0.770 |
Why?
|
Immunoglobulin A | 6 | 2021 | 978 | 0.690 |
Why?
|
GTP-Binding Proteins | 4 | 2020 | 951 | 0.680 |
Why?
|
Lost to Follow-Up | 1 | 2018 | 123 | 0.600 |
Why?
|
Gastrointestinal Diseases | 2 | 2022 | 1200 | 0.550 |
Why?
|
Dyspepsia | 1 | 2017 | 116 | 0.530 |
Why?
|
Endoscopy, Digestive System | 1 | 2019 | 351 | 0.530 |
Why?
|
Delayed Diagnosis | 1 | 2020 | 463 | 0.510 |
Why?
|
Gastrointestinal Tract | 1 | 2020 | 833 | 0.470 |
Why?
|
Colitis, Ulcerative | 2 | 2023 | 1922 | 0.450 |
Why?
|
Crohn Disease | 2 | 2023 | 2279 | 0.440 |
Why?
|
Mitochondrial Proton-Translocating ATPases | 3 | 2006 | 53 | 0.390 |
Why?
|
Autoantibodies | 4 | 2021 | 2116 | 0.380 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2016 | 4016 | 0.360 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2024 | 3415 | 0.330 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2023 | 2422 | 0.320 |
Why?
|
Feces | 3 | 2020 | 1497 | 0.320 |
Why?
|
Autoimmunity | 1 | 2016 | 1356 | 0.310 |
Why?
|
Budesonide | 2 | 2020 | 157 | 0.310 |
Why?
|
Child | 20 | 2024 | 80156 | 0.310 |
Why?
|
Self Report | 2 | 2019 | 3725 | 0.310 |
Why?
|
Biopsy | 8 | 2024 | 6766 | 0.290 |
Why?
|
Humans | 59 | 2024 | 761572 | 0.280 |
Why?
|
Gastrointestinal Agents | 2 | 2023 | 510 | 0.270 |
Why?
|
HLA-DQ Antigens | 2 | 2024 | 191 | 0.270 |
Why?
|
Gliadin | 3 | 2021 | 80 | 0.260 |
Why?
|
Atrophy | 2 | 2022 | 1633 | 0.240 |
Why?
|
Feeding Behavior | 1 | 2016 | 3188 | 0.230 |
Why?
|
Life Style | 1 | 2015 | 3917 | 0.220 |
Why?
|
Lymphocytosis | 1 | 2024 | 121 | 0.210 |
Why?
|
Emotions | 1 | 2015 | 2739 | 0.210 |
Why?
|
Irritable Bowel Syndrome | 2 | 2019 | 455 | 0.200 |
Why?
|
Food Contamination | 2 | 2020 | 191 | 0.200 |
Why?
|
Esophagitis | 1 | 2023 | 164 | 0.200 |
Why?
|
Immunologic Tests | 1 | 2020 | 104 | 0.170 |
Why?
|
Anti-Inflammatory Agents | 2 | 2020 | 1809 | 0.170 |
Why?
|
Prospective Studies | 6 | 2023 | 54426 | 0.170 |
Why?
|
Habits | 1 | 2020 | 147 | 0.170 |
Why?
|
Immunization | 1 | 2024 | 1227 | 0.170 |
Why?
|
Female | 26 | 2024 | 392686 | 0.160 |
Why?
|
Immunoassay | 2 | 2019 | 745 | 0.160 |
Why?
|
Food Industry | 1 | 2019 | 67 | 0.160 |
Why?
|
Adult | 17 | 2023 | 221203 | 0.150 |
Why?
|
Antibodies | 2 | 2023 | 2418 | 0.150 |
Why?
|
Haplotypes | 1 | 2024 | 2713 | 0.150 |
Why?
|
Drug Monitoring | 1 | 2023 | 962 | 0.150 |
Why?
|
Mouth Diseases | 1 | 2020 | 241 | 0.140 |
Why?
|
Food Labeling | 1 | 2020 | 179 | 0.140 |
Why?
|
Male | 23 | 2024 | 360842 | 0.140 |
Why?
|
Immunity, Cellular | 1 | 2022 | 1560 | 0.140 |
Why?
|
Nutrition Assessment | 1 | 2020 | 728 | 0.140 |
Why?
|
Predictive Value of Tests | 3 | 2024 | 15266 | 0.140 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2019 | 828 | 0.130 |
Why?
|
Practice Guidelines as Topic | 3 | 2023 | 7391 | 0.130 |
Why?
|
Pregnant Women | 1 | 2020 | 566 | 0.130 |
Why?
|
Disease Management | 2 | 2020 | 2508 | 0.120 |
Why?
|
Single-Blind Method | 1 | 2019 | 1574 | 0.120 |
Why?
|
Sensitivity and Specificity | 3 | 2021 | 14666 | 0.120 |
Why?
|
Down Syndrome | 1 | 2023 | 901 | 0.120 |
Why?
|
Protein Precursors | 1 | 2019 | 1132 | 0.120 |
Why?
|
Siblings | 1 | 2018 | 825 | 0.120 |
Why?
|
Immunologic Factors | 1 | 2023 | 1589 | 0.120 |
Why?
|
Seasons | 1 | 2020 | 1520 | 0.120 |
Why?
|
Adolescent | 9 | 2024 | 88324 | 0.120 |
Why?
|
Middle Aged | 12 | 2020 | 220920 | 0.110 |
Why?
|
Eye Diseases | 1 | 2020 | 653 | 0.110 |
Why?
|
Constipation | 1 | 2019 | 563 | 0.110 |
Why?
|
Autistic Disorder | 1 | 2023 | 1220 | 0.110 |
Why?
|
Evidence-Based Medicine | 2 | 2021 | 3688 | 0.110 |
Why?
|
Musculoskeletal Diseases | 1 | 2020 | 598 | 0.110 |
Why?
|
Eating | 1 | 2020 | 1539 | 0.110 |
Why?
|
Restaurants | 1 | 2016 | 231 | 0.110 |
Why?
|
Child, Preschool | 6 | 2024 | 42230 | 0.110 |
Why?
|
Young Adult | 6 | 2023 | 59255 | 0.110 |
Why?
|
Malnutrition | 1 | 2020 | 645 | 0.110 |
Why?
|
Social Isolation | 1 | 2015 | 364 | 0.100 |
Why?
|
Diarrhea | 1 | 2019 | 1318 | 0.100 |
Why?
|
Integrin alpha5 | 1 | 2011 | 20 | 0.100 |
Why?
|
Colon | 1 | 2019 | 1792 | 0.100 |
Why?
|
Skin Diseases | 1 | 2020 | 1094 | 0.090 |
Why?
|
Canada | 2 | 2019 | 2122 | 0.090 |
Why?
|
Severity of Illness Index | 2 | 2024 | 15843 | 0.090 |
Why?
|
rho GTP-Binding Proteins | 1 | 2011 | 276 | 0.080 |
Why?
|
Caveolin 1 | 1 | 2011 | 256 | 0.080 |
Why?
|
Infant | 5 | 2024 | 36192 | 0.080 |
Why?
|
Nervous System Diseases | 1 | 2020 | 1667 | 0.080 |
Why?
|
Retrospective Studies | 10 | 2024 | 80646 | 0.080 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 615 | 0.080 |
Why?
|
src-Family Kinases | 1 | 2011 | 535 | 0.080 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2018 | 2425 | 0.080 |
Why?
|
Communicable Diseases | 1 | 2016 | 875 | 0.080 |
Why?
|
Prevalence | 3 | 2024 | 15732 | 0.070 |
Why?
|
Pyrazoles | 1 | 2018 | 2009 | 0.070 |
Why?
|
Cohort Studies | 3 | 2020 | 41493 | 0.070 |
Why?
|
Peptides | 1 | 2019 | 4358 | 0.070 |
Why?
|
Cell Cycle Proteins | 1 | 2018 | 3449 | 0.070 |
Why?
|
ras Proteins | 1 | 2011 | 1054 | 0.070 |
Why?
|
Cattle | 3 | 2006 | 3849 | 0.060 |
Why?
|
Biomedical Research | 1 | 2021 | 3429 | 0.060 |
Why?
|
Diagnosis, Differential | 1 | 2021 | 12975 | 0.060 |
Why?
|
Referral and Consultation | 1 | 2018 | 3600 | 0.060 |
Why?
|
Pyrimidines | 1 | 2018 | 3028 | 0.060 |
Why?
|
X-Ray Diffraction | 1 | 2006 | 421 | 0.060 |
Why?
|
Medicaid | 1 | 2018 | 2818 | 0.060 |
Why?
|
Crystallization | 1 | 2006 | 534 | 0.060 |
Why?
|
Vaccination | 1 | 2016 | 3384 | 0.060 |
Why?
|
Wetlands | 1 | 2024 | 13 | 0.060 |
Why?
|
Gene Expression Profiling | 1 | 2019 | 9420 | 0.050 |
Why?
|
Longitudinal Studies | 1 | 2020 | 14607 | 0.050 |
Why?
|
Body Mass Index | 1 | 2021 | 12954 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 2 | 2024 | 17904 | 0.050 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2018 | 5305 | 0.050 |
Why?
|
Cadmium | 1 | 2024 | 214 | 0.050 |
Why?
|
Histocytochemistry | 1 | 2023 | 698 | 0.050 |
Why?
|
Self Care | 1 | 2007 | 796 | 0.050 |
Why?
|
Clinical Laboratory Techniques | 1 | 2007 | 746 | 0.050 |
Why?
|
Pandemics | 1 | 2022 | 8656 | 0.050 |
Why?
|
Age Factors | 1 | 2018 | 18398 | 0.050 |
Why?
|
Costs and Cost Analysis | 1 | 2007 | 1668 | 0.050 |
Why?
|
Protein Kinase Inhibitors | 1 | 2018 | 5672 | 0.050 |
Why?
|
Intestines | 1 | 2010 | 1909 | 0.050 |
Why?
|
IgA Deficiency | 1 | 2020 | 39 | 0.040 |
Why?
|
Bread | 1 | 2020 | 23 | 0.040 |
Why?
|
Seroepidemiologic Studies | 1 | 2021 | 397 | 0.040 |
Why?
|
Mitochondrial Proteins | 1 | 2006 | 976 | 0.040 |
Why?
|
Mental Disorders | 1 | 2020 | 6845 | 0.040 |
Why?
|
Multiprotein Complexes | 1 | 2006 | 1120 | 0.040 |
Why?
|
Tablets, Enteric-Coated | 1 | 2019 | 20 | 0.040 |
Why?
|
Aged | 3 | 2020 | 169310 | 0.040 |
Why?
|
Pregnancy | 1 | 2020 | 29876 | 0.040 |
Why?
|
United States | 3 | 2024 | 72335 | 0.040 |
Why?
|
Diet Therapy | 1 | 2018 | 151 | 0.040 |
Why?
|
Haptoglobins | 1 | 2019 | 166 | 0.040 |
Why?
|
Quality of Life | 2 | 2018 | 13367 | 0.040 |
Why?
|
Duodenoscopy | 1 | 2017 | 45 | 0.040 |
Why?
|
Research Support as Topic | 1 | 2021 | 697 | 0.040 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2023 | 874 | 0.030 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2019 | 296 | 0.030 |
Why?
|
Permeability | 1 | 2019 | 723 | 0.030 |
Why?
|
Lymphocytes | 1 | 2024 | 2612 | 0.030 |
Why?
|
China | 1 | 2021 | 2374 | 0.030 |
Why?
|
Food | 1 | 2020 | 774 | 0.030 |
Why?
|
Developmental Disabilities | 1 | 2023 | 1509 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2024 | 22176 | 0.030 |
Why?
|
Myocardial Contraction | 1 | 1999 | 1515 | 0.030 |
Why?
|
Follow-Up Studies | 3 | 2021 | 39107 | 0.030 |
Why?
|
Genomic Instability | 1 | 2018 | 709 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 3810 | 0.030 |
Why?
|
Oligopeptides | 1 | 2018 | 1187 | 0.030 |
Why?
|
Guidelines as Topic | 1 | 2019 | 1386 | 0.030 |
Why?
|
Adenosine Triphosphate | 1 | 1999 | 1989 | 0.030 |
Why?
|
Vitamins | 1 | 2021 | 1635 | 0.030 |
Why?
|
Intestine, Small | 1 | 2019 | 1206 | 0.030 |
Why?
|
Mitosis | 1 | 2018 | 1188 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2020 | 4853 | 0.030 |
Why?
|
Crk-Associated Substrate Protein | 1 | 2011 | 39 | 0.020 |
Why?
|
Risk Factors | 2 | 2024 | 74213 | 0.020 |
Why?
|
Child Development | 1 | 2023 | 2306 | 0.020 |
Why?
|
Myocardium | 1 | 2004 | 4725 | 0.020 |
Why?
|
Colonoscopy | 1 | 2019 | 1394 | 0.020 |
Why?
|
Mitochondria | 1 | 2004 | 3624 | 0.020 |
Why?
|
Schools | 1 | 2020 | 1489 | 0.020 |
Why?
|
Administration, Oral | 1 | 2019 | 4021 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2024 | 26198 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2019 | 2161 | 0.020 |
Why?
|
Chick Embryo | 1 | 2011 | 982 | 0.020 |
Why?
|
Diet | 1 | 2007 | 8075 | 0.020 |
Why?
|
Societies, Medical | 1 | 2021 | 3905 | 0.020 |
Why?
|
Cost of Illness | 1 | 2018 | 1936 | 0.020 |
Why?
|
Myocardial Ischemia | 1 | 1999 | 2113 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 1999 | 3713 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2019 | 5247 | 0.020 |
Why?
|
Animals | 6 | 2021 | 168467 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2018 | 16986 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2020 | 10766 | 0.020 |
Why?
|
Boston | 1 | 2021 | 9326 | 0.020 |
Why?
|
Immunoblotting | 1 | 2011 | 1646 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2020 | 4369 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2019 | 64684 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2011 | 2748 | 0.020 |
Why?
|
Recurrence | 1 | 2019 | 8466 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2023 | 10212 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2020 | 12341 | 0.020 |
Why?
|
Mice, SCID | 1 | 2011 | 2626 | 0.020 |
Why?
|
Heart | 1 | 1999 | 4404 | 0.020 |
Why?
|
Neoplasms, Experimental | 1 | 2011 | 1229 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2011 | 3597 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 9280 | 0.020 |
Why?
|
RNA Interference | 1 | 2011 | 2832 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2023 | 26127 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2004 | 3769 | 0.010 |
Why?
|
Crystallography, X-Ray | 1 | 2006 | 1990 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2019 | 20099 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2011 | 4915 | 0.010 |
Why?
|
Phosphorylation | 1 | 2011 | 8321 | 0.010 |
Why?
|
Mice | 2 | 2021 | 81533 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2011 | 13446 | 0.010 |
Why?
|
Cell Movement | 1 | 2011 | 5205 | 0.010 |
Why?
|
Isoproterenol | 1 | 1999 | 395 | 0.010 |
Why?
|
Protein Binding | 1 | 2011 | 9353 | 0.010 |
Why?
|
Phosphocreatine | 1 | 1999 | 261 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2011 | 17635 | 0.010 |
Why?
|
Myocardial Reperfusion | 1 | 1999 | 338 | 0.010 |
Why?
|
Isoquinolines | 1 | 1999 | 352 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2004 | 3792 | 0.010 |
Why?
|
Systole | 1 | 1999 | 936 | 0.010 |
Why?
|
Diastole | 1 | 1999 | 782 | 0.010 |
Why?
|
Cardiotonic Agents | 1 | 1999 | 539 | 0.010 |
Why?
|
Models, Molecular | 1 | 2006 | 5439 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2011 | 22172 | 0.010 |
Why?
|
Ventricular Dysfunction, Left | 1 | 1999 | 2118 | 0.000 |
Why?
|
Rats, Sprague-Dawley | 1 | 1999 | 8181 | 0.000 |
Why?
|
Blood Pressure | 1 | 1999 | 8481 | 0.000 |
Why?
|
Rats | 1 | 1999 | 23741 | 0.000 |
Why?
|